Close Menu
Rupee WiseRupee Wise
  • Indian Markets
  • Block Deals
  • Commodities
  • Earnings Reports
  • Global Insights
  • Bonds
  • Market Analysis
Recent Posts
  • GIFT Nifty Opens Marginally Down, Signaling Muted Start for Indian Equities
  • NSE Nifty Shows Positive Start: Pre-Open Trade Indicates Upward Momentum
  • GIFT NIFTY Opens Marginally Lower, Signaling Cautious Start for Indian Markets
  • Indian Market Opens with a Slight Dip: Nifty Down 0.18% in Pre-Open Trade
  • Indian Market Pre-Open Shows Positive Start: Nifty Opens Up 0.27%
  • English
  • हिन्दी
Archives
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • July 2024
WhatsApp
WhatsApp
  • English
  • हिन्दी
Rupee WiseRupee Wise
  • Indian Markets
  • Block Deals
  • Commodities
  • Earnings Reports
  • Global Insights
  • Bonds
  • Market Analysis
Rupee WiseRupee Wise
  • English
  • हिन्दी
  • Indian Markets
  • Block Deals
  • Commodities
  • Earnings Reports
  • Global Insights
  • Bonds
  • Market Analysis
Home » Latest News » Markets » Indian Markets

Piramal Pharma Faces Anti-Dumping Investigation on Vitamin-A Palmitate Imports

3 months ago Indian Markets 2 Mins Read
  • India initiates an anti-dumping investigation concerning imports of “Vitamin-A Palmitate” originating in or exported from China, the European Union, and Switzerland.
  • This investigation follows a petition filed by Piramal Pharma Limited, alleging that the dumping of this product harms domestic industries.
  • The Directorate General of Trade Remedies (DGTR), the investigative arm of India’s commerce ministry, conducts the probe.
  • The DGTR assesses whether Vitamin-A Palmitate is being imported at prices below its normal value, causing material injury to Indian producers.
  • If the investigation finds evidence of dumping and injury, the DGTR may recommend the imposition of anti-dumping duties.
  • It is important to note that later on, Piramal Pharma withdrew their request, and the DGTR halted the anti-dumping investigation.

Key Insights:

  • The primary focus of this investigation is to protect domestic manufacturers from unfair competition caused by the dumping of imported goods.
  • Key events include Piramal Pharma’s petition, the DGTR’s initiation of the investigation, and the following investigation process, and then the withdrawl of the petition by Piramal Pharma.
  • The investigation has the potential to impact the pricing and availability of Vitamin-A Palmitate in the Indian market.
  • This action reflects India’s commitment to enforcing fair trade practices and supporting its domestic pharmaceutical industry.
  • The withdrawal of the petition shows how market conditions can change, and how companies will change their strategies to adapt to the market.

Investment Implications:

  • The initial investigation creates uncertainty for companies involved in the import and distribution of Vitamin-A Palmitate.
  • If anti-dumping duties are imposed, it could lead to increased prices for consumers and potential shifts in market share.
  • For Piramal Pharma, the investigation initially signaled an effort to strengthen its position in the domestic market. However, the withdrawl of the petition changes the outlook.
  • Investors should monitor the DGTR’s findings and any subsequent actions taken by the government.
  • Because the investigation has been halted, the market for Vitamin-A Palmitate should return to normal.
Follow on WhatsApp Follow on Google News
Share. WhatsApp Telegram Facebook Twitter Email LinkedIn Copy Link
Avatar of Rajiv Kumar
Rajiv Kumar
  • Website

Rajiv Kumar is a stock broker and financial consultant with a deep understanding of the market. He owns a successful firm where he helps individuals and companies make smart investment decisions. Rajiv provides personalized advice and strategies to help his clients achieve their financial goals. His expertise and commitment to client satisfaction have earned him a strong reputation in the finance industry.

Keep Reading

Indian Markets 3 weeks ago

Aster DM Healthcare Leases Land for New Hospital in Bengaluru

3 Mins Read
Indian Markets 3 weeks ago

Exide Industries’ Q4 FY25 EBITDA Margins Affected by Higher Raw Material Prices

3 Mins Read
Indian Markets 3 weeks ago

Alembic Pharma Anticipates Margin Expansion Driven by R&D Optimization

2 Mins Read
Indian Markets 3 weeks ago

Paytm Reaffirms Margin Targets, Highlights Earnings Potential

3 Mins Read
Indian Markets 3 weeks ago

Welspun Corp Secures Significant Export Order for Coated LSAW Line Pipes and Bends from India

2 Mins Read
Indian Markets 3 weeks ago

Techno Electric Launches Digital Infrastructure Arm with USD 1 Billion Investment Plan

3 Mins Read
Indian Markets 3 weeks ago

Report of Sumitomo Acquiring 51% Stake in YES BANK Incorrect, Say Banking Sources

2 Mins Read
Indian Markets 3 weeks ago

Meghna Infracon Board to Consider Bonus Share Issuance

2 Mins Read
Indian Markets 3 weeks ago

Hyundai Motor India Celebrates 29 Years of Success with 12.7 Million Units Sold

2 Mins Read
Indian Markets 3 weeks ago

Indian Hotels Confident in Double-Digit Growth Fueled by Expansion and Asset Management

2 Mins Read
Indian Markets 3 weeks ago

Sunteck Realty Expresses Confidence in Continued Growth and Acquisition Strategy

2 Mins Read
Indian Markets 3 weeks ago

Coforge Bullish on FY26 Outlook, Expects Margin Expansion

2 Mins Read
Add A Comment
Leave A Reply Cancel Reply

Latest Posts

GIFT Nifty Opens Marginally Down, Signaling Muted Start for Indian Equities

7 hours ago

NSE Nifty Shows Positive Start: Pre-Open Trade Indicates Upward Momentum

1 day ago

GIFT NIFTY Opens Marginally Lower, Signaling Cautious Start for Indian Markets

2 days ago

Indian Market Opens with a Slight Dip: Nifty Down 0.18% in Pre-Open Trade

3 days ago

Indian Market Pre-Open Shows Positive Start: Nifty Opens Up 0.27%

4 days ago

Nifty50 Closes Strong, Up 0.95% at 24,845.15

7 days ago

NSE Opens Lower: Indian Equities Decline in Pre-Open Trade

1 week ago
Tags
Banking Sector Block Trade Brent Crude Construction Crude Oil DII EBITDA Electric Vehicles Energy Sector FII GIFT Nifty Global Economy India Indian Economy Indian Stock Market Inflation Infrastructure Institutional Investment Institutional Investors Investment Investment Strategy Manufacturing Market Sentiment Market Volatility Mergers and Acquisitions NBFC Nifty 50 Nifty50 NSE Oil Prices OPEC+ Order Book Pharmaceutical Industry Pharmaceuticals Pharmaceutical Sector Power Sector Profitability Q2 Results Quarterly Results Real Estate Renewable Energy Revenue Growth Stock Market निवेश शेयर बाजार
© 2025 RupeeWise. Powered by ABLORE.

Type above and press Enter to search. Press Esc to cancel.